GARETATUG
UNII 9QF4QB7XAX

Substance Identification & Data

This profile provides standardized clinical and technical data for Garetatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9QF4QB7XAX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3023285-05-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9QF4QB7XAX
CAS Registry Number
3023285-05-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GARETATUG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C216031
National Cancer Institute reference terminology for clinical and research data.
INN ID
13529
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Garetatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GARETATUG

Common Names & Synonyms

GARETATUG [INN]
H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV1-3*01 (87.8%) -(IGHD) -IGHJ4*01 (92.9%) L123>T (113), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 D12 (357), L14 (359) (342-446), CHS (447-448)) (119-448)), (221-220')-DISULFIDE WITH LKAPPA LIGHT CHAIN HUMANIZED (1'-220') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (90.1%) -IGKJ2*02 (100%), CDR-IMGT (12.3.9) (27'-38'.56'-58'.95'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN-18 ISOFORM A2) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00965 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HRP00965 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), HUMANIZED MONOCLONAL ANTIBODY (GARETATUG)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus